Select Page

Biogen’s big reveal & the science of one-eyed sheep

Biogen’s big reveal & the science of one-eyed sheep



How do you know if a “positive” study is positive? And what if clinical trial participants unionized?

We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, we dig into Biogen’s (BIIB) much-dissected data on a treatment for Alzheimer’s disease, with on-the-ground takes from experts at a scientific conference. Then, STAT’s Eric Boodman joins us to spin a drug-discovery yarn involving one-eyed sheep, Basque farmers, and the quest to treat a rare form of cancer.

For more on what we cover, here’s the Biogen news, and here’s the story on the hunt for a new medicine.

advertisement

We’ll be back next Thursday evening — and every Thursday evening — so be sure to sign up on Apple Podcasts, Stitcher, Google (GOOGL) Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email readoutloud@statnews.com.


Interested in sponsoring a future episode of “The Readout LOUD”? Email us at marketing@statnews.com.





Source link

About The Author

Leave a reply

Your email address will not be published. Required fields are marked *